tiprankstipranks
Design Therapeutics (DSGN)
NASDAQ:DSGN
US Market

Design Therapeutics (DSGN) Stock Investors

72 Followers
Based on 746,803 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold DSGN
On average, investors allocate 0.00% of their portfolios to DSGN
The average holding size of this company in investors' portfolios.

Investor Sentiment

Very Negative
Sector
Average
Stock Sentiment
Sold
Bought
Based on the activity of 746,803 investors in the recent quarter
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding DSGN

1.7%
Last 7
Days
1.5%
Last 30
Days
Percentages indicate the change in the number of portfolios holding DSGN, out of 746,803 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

DSGN Investor Activity

Action
Any
Any
Investor Performance
Any
Any
No data currently available
Based on the activity of 14,170 investors who made their portfolios public
The table shows changes in DSGN in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

DSGN Investors Also Bought

Investor Type
Any
Any
All Investors
Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
Coherus Biosciences
2.56%
-1.64%
-4.99%
189.30M
Healthcare
DraftKings
5.86%
-1.32%
-1.44%
34.65B
Consumer Cyclical
ChargePoint Holdings
4.22%
-1.16%
-2.22%
927.16M
Consumer Cyclical
PDD Holdings
4.98%
+0.56%
+3.91%
183.33B
Consumer Cyclical
Applied Materials
4.70%
+0.22%
+6.34%
203.31B
Technology
Marathon Digital Holdings
5.79%
-0.34%
+0.22%
6.71B
Financial
Riot Platforms
5.08%
-0.61%
+0.89%
3.32B
Financial
Devon Energy
5.31%
-0.39%
+4.44%
30.15B
Energy
Merck & Company
3.90%
+0.27%
+4.31%
324.50B
Healthcare
C3ai
6.06%
-0.42%
+3.41%
3.82B
Technology
Based on the activity of 746,803 active portfolios
Open your Smart Portfolio

DSGN Investor Analysis

DSGN investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
37.0%
of DSGN holders
are under 35
Average Segment Performance
Average P/E Ratio21.96
Beta7.16
Dividend Yield6.43%
DSGN investors between 35–55

Between 35–55

0.0%
Last 30 days
Holdings Change
44.4%
of DSGN holders
are between 35–55
Average Segment Performance
Average P/E Ratio20.75
Beta11.80
Dividend Yield6.41%
DSGN investors over 55

Over 55

0.0%
Last 30 days
Holdings Change
18.5%
of DSGN holders
are over 55
Average Segment Performance
Average P/E Ratio20.82
Beta3.95
Dividend Yield7.83%
Overview of age group and performance of DSGN stock investors
See who invests in DSGN according to age group and performance.

FAQ

How many retail Investors hold DSGN?
<0.1% of TipRanks' retail investors hold DSGN in their portfolios.
    What is DSGN Investor Sentiment?
    DSGN’s Investor Sentiment is Very Negative.
      What percentage of retail investors changed their holding of DSGN in the last 7 days?
      ▼ 1.7% of TipRanks' retail investors changed their holding of DSGN in the last 7 days.
        What percentage of retail investors changed their holding of DSGN in the last 30 days?
        ▼ 1.5% of TipRanks' retail investors changed their holding of DSGN in the last 30 days.
          What is the average age of retail investors who hold DSGN?
          The average age of DSGN Holders is between 35–55.
            What other stocks have DSGN investors also bought?
            DSGN Investors also bought CHRS, DKNG, CHPT, PDD, AMAT, MARA, RIOT, DVN, MRK, AI.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              BCRXBioCryst
              BSXBoston Scientific
              CYTKCytokinetics
              EWEdwards Lifesciences
              AVDLAvadel Pharmaceuticals
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis